EBITDA rose to CZK 1.85bn in 2025 with 28% revenue growth, driven by acquisitions in cosmetics and Latin America. New product launches and improved capital discipline support a positive 2026 outlook, targeting up to 10% revenue growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.